This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

541 Wed, 8/4/2010, 12:30 PM - 1:50 PM CC-Ballroom D (West)
Biopharmaceutical Section P.M. Roundtable Discussion (fee event) — Roundtables PM Roundtable Discussion
Biopharmaceutical Section
Organizer(s): Jeffrey Maca, Novartis Pharmaceuticals Corporation
WL10: Data Safety Monitoring Boards (DSMB) for International Clinical Trials Sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) Rebecca DerSimonian, National Institutes of Health
WL11: Genomics in the Pharmaceutical Industry: Where Is It Headed? Dhammika Amaratunga, Johnson & Johnson ; James Colaianne, Johnson & Johnson
WL12: Statistical Issues in Adaptive Design Wei Zhang, FDA/CVM
WL13: Multiplicity Issues in Multidomain Patient Reported Outcome (PRO)--Based Endpoints Mahboob Sobhan, FDA
WL14: Demonstrating Superiority of Test Drug to Putative Placebo in the Two-Arm Noninferiority Trial Abdul J. Sankoh, Vertex Pharmaceuticals
WL15: Careers for a Biostatistician Katherine Monti, Rho, Inc.

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.